Collectively, the current study demonstrates that the anti-obesity effect of myricetin was mediated through the upregulation of Sirt3 expression and the subsequent activation of mitochondrial fatty acid oxidation. Here, SIRT3 is linked to obesity due to melanocortin 4 receptor deficiency.